Core B. Genomics and Bioinformatics Core
Core B. Genomics and Bioinformatics Core
批准号:
10625575
负责人:
Frederic D Bushman
金额:
$16.78万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2028-02-29
关键词:
AffectAntigensArchivesBacteriophagesBioinformaticsCanis familiarisCattleCellsClinicalClostridium difficileCollaborationsComparative StudyDNADNA Modification ProcessDNA Sequence AlterationDataGene Expression ProfilingGenesGenetic VariationGenomeGenomicsHumanHybridsImmune responseImmunodeficient MouseImmunologyInfectionIntestinesInvestigationMembrane ProteinsMessenger RNAMethodsMusOutcomePopulationPopulation HeterogeneityProtein AnalysisProteinsRNA vaccineReportingResourcesSamplingSequence AnalysisStatistical Data InterpretationStructureSystemVaccinatedVaccinesVariantWorkarchive datadata archivedata managementdesigndiverse datafascinatein vivointerestmetatranscriptomicsmicrobiomemicrobiome compositionmicrobiome sequencingmodel organismprotein structureresponsestatisticstranscription factortranscriptome sequencingtransposon/insertion elementvaccine candidatevaccine efficacy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY- CORE B (GENOMICS CORE)
Core B (Genomics Core) will provide key support to the mVACS team in Clostridioides difficile genome sequence
analysis, antigen design, microbiome sequence analysis, routine statistical analysis, and high content data
management. Core B will use advanced genomics-based methods to quantify C. difficile genome composition
and genetic variation, and associate these with outcomes. Core B will support analysis of protein structure to
allow expression of well-folded domains as mRNAs. Core B will characterize DNA inversion systems and other
mechanisms of DNA modification and alterations in gene activity that may impact vaccine efficacy. Core B will
also carry out transcriptional profiling on C. difficile isolated from the intestine of vaccinated and immunodeficient
mice, to assess how C. difficile responds in vivo to effective and ineffective immune responses. The Aims of
Core B are: (1) C. difficile genomics to identify optimal targets for modified mRNA vaccines. Long read and short
read data will be merged to generate complete assemblies, as in our previous work. Gene content will be
enumerated and compared with clinical outcomes. (2) To assess variation in sequence and abundance of C.
difficile vaccine targets. C. difficile isolates are known to encode considerable variation in their surface proteins.
In addition, DNA inversion systems encode on-off switches affecting surface proteins and transcription factors,
resulting in extensive population heterogeneity. This Aim will thus carry out deep assessment of proteins relevant
as modified mRNA vaccine targets, and guide antigen design. (3) Transcriptional profiling and microbiome
sequencing for mechanistic investigation. Projects 1-3 and the Clinical Core will generate murine and human
fecal samples associated with successful or unsuccessful responses to C. difficile infection; Core B will quantify
microbiome composition and metatranscriptomic analysis of C. difficile positive samples by RNA-seq. This core
will oversee sequence acquisition and analysis is support of these studies. (4) Data management and archiving.
Core C will work with Core A for standard statistical analysis and will archive and manage the diverse data types
generated by the U19 team.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mVACS--mRNA Vaccines for C. difficile Suppression
-
批准号:10625573
-
项目类别:
-
资助金额:$153.0万
-
财政年份:2023
-
负责人:Frederic D Bushman
-
依托单位:
Preserving Genome Integrity In AAV-Mediated Gene Therapy
-
批准号:10338480
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2022
-
负责人:Frederic D Bushman
-
依托单位:
Preserving Genome Integrity In AAV-Mediated Gene Therapy
-
批准号:10558679
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2022
-
负责人:Frederic D Bushman
-
依托单位:
Core B: Genome Engineering Core
-
批准号:10450647
-
项目类别:
-
资助金额:$16.65万
-
财政年份:2020
-
负责人:Frederic D Bushman
-
依托单位:
Core B: Genome Engineering Core
-
批准号:10617345
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2020
-
负责人:Frederic D Bushman
-
依托单位:
Core B: Genome Engineering Core
-
批准号:10165493
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2020
-
负责人:Frederic D Bushman
-
依托单位:
Core B: Genome Engineering Core
-
批准号:9891734
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2020
-
负责人:Frederic D Bushman
-
依托单位:
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
-
批准号:10398224
-
项目类别:
-
资助金额:$60.03万
-
财政年份:2019
-
负责人:Frederic D Bushman
-
依托单位:
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
-
批准号:10158019
-
项目类别:
-
资助金额:$62.11万
-
财政年份:2019
-
负责人:Frederic D Bushman
-
依托单位:
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
-
批准号:10640072
-
项目类别:
-
资助金额:$59.21万
-
财政年份:2019
-
负责人:Frederic D Bushman
-
依托单位:
The Lung DNA Virome in Health and Disease
-
批准号:9926300
-
项目类别:
-
资助金额:$74.96万
-
财政年份:2017
-
负责人:Frederic D Bushman
-
依托单位:
The Lung DNA Virome in Health and Disease
-
批准号:9303685
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2017
-
负责人:Frederic D Bushman
-
依托单位:
Optimization HIV Inhibition by Allosteric Integrase Inhibitors
-
批准号:10077786
-
项目类别:
-
资助金额:$43.43万
-
财政年份:2017
-
负责人:Frederic D Bushman
-
依托单位:
The Lung DNA Virome in Health and Disease
-
批准号:9475867
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2017
-
负责人:Frederic D Bushman
-
依托单位:
Lung Transplant Microbiome and Chronic Allograft Dysfunction
-
批准号:9066196
-
项目类别:
-
资助金额:$72.7万
-
财政年份:2013
-
负责人:Frederic D Bushman
-
依托单位:
Lung Transplant Microbiome and Chronic Allograft Dysfunction
-
批准号:8665468
-
项目类别:
-
资助金额:$73.69万
-
财政年份:2013
-
负责人:Frederic D Bushman
-
依托单位:
Lung Transplant Microbiome and Chronic Allograft Dysfunction
-
批准号:8847785
-
项目类别:
-
资助金额:$72.97万
-
财政年份:2013
-
负责人:Frederic D Bushman
-
依托单位:
Lung Transplant Microbiome and Chronic Allograft Dysfunction
-
批准号:8505677
-
项目类别:
-
资助金额:$74.29万
-
财政年份:2013
-
负责人:Frederic D Bushman
-
依托单位:
Inhibition of DNA modifying enzymes of category A-C agents
-
批准号:8233378
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2011
-
负责人:Frederic D Bushman
-
依托单位:
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease
-
批准号:8119642
-
项目类别:
-
资助金额:$80.46万
-
财政年份:2009
-
负责人:Frederic D Bushman
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: